Imagine a world where 6,000 genetic diseases…
From skin cancer to diabetes are a thing of the past.
That’s what President Trump envisioned within days of taking office…
By signing “Executive Order 13771.”
To spearhead what 60 Minutes and the Nobel Laureate Committeehave hailed as “the most consequential discovery in biomedicine this century” and the “Holy Grail” of medicine.
Now, this is not just a distant dream.
The UK’s recent approval of a CRISPR-based therapy…
Targeting sickle-cell disease and β-thalassaemia, marks a monumental step…
In realizing this vision.
This gene-editing technology, capable of altering the DNA in blood-producing stem cells…
Offers a glimpse into a future where genetic diseases are effectively cured.
Yet, with Biden’s repeal of this executive order…
What will it mean for the future of such groundbreaking medical advancements?
Are we stepping back from a technology that could create more millionaires than any other in history?
Click Here to Uncover the Full Story >>
Stay informed,
Simmy Adelman
Editor,
Behind the Markets
